Global WASHOUT Study Reveals Critical 48-Hour Window to Reduce Mortality for Emergency Urology Patients

Discover how immediate scans for blood in urine can reduce 90-day mortality and accelerate cancer diagnosis for thousands of emergency patients worldwide.

By: AXL Media

Published: Mar 16, 2026, 7:30 AM EDT

Source: Information for this report was sourced from European Association of Urology

The Lethal Risk of Diagnostic Delays

Emergency hospital admissions involving visible blood in the urine, known clinically as gross hematuria, carry a surprisingly high mortality rate that has long been underestimated by the medical community. The global WASHOUT study, involving over 8,500 patients across 380 hospitals, has revealed that 10% of these individuals die within three months of their initial emergency room visit. Despite the severity of this symptom, many patients "fall through the gaps" because the issue is not always immediately linked to a specific underlying disease. The research highlights that visible blood is often a primary indicator of critical illness, yet current hospital responses remain inconsistent due to a lack of evidence based global guidelines.

Diagnostic Urgency and the 48-Hour Standard

The study identifies a critical 48 hour window for performing investigative tests, such as CT scans or cystoscopies, to evaluate the bladder and kidneys. Patients who received these investigations within the first two days of arrival were far more likely to survive the following three months. Conversely, those who did not receive rapid diagnostic imaging were 2.5% more likely to die within 90 days. Beyond survival, immediate testing also reduced the total time spent in the hospital and lowered the probability of readmission for the same issue. According to lead researcher Nikita Bhatt, identifying the cause of the problem early is the most effective way to improve long term patient outcomes.

Hidden Malignancies and Accelerated Detection

Visible blood in the urine serves as a significant "red flag" for underlying malignancies, with the study finding that one in four emergency patients was eventually diagnosed with cancer. Bladder cancer was identified as the most common underlying cause among this cohort. For patients who underwent investigative tests within the first 48 hours of admission, the average time to a cancer diagnosis was just one day. In stark contrast, patients who were discharged without immediate investigation faced an average wait of three weeks before receiving a diagnosis. This delay can be catastrophic for aggressive cancers, where every week of postponed treatment can impact the overall prognosis.